×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
HRTXHERON THERAPEUTICS, INC. /DE/Peraza LisaVP, Chief Accounting OfficerJan 13, 2024Option Exercise$2.157561,62555,907Jan 16, 2024, 05:19 PM
HRTXHERON THERAPEUTICS, INC. /DE/Forbes William PEVP, Chief Development OfficerNov 17, 2023Buy$1.0925,00027,25079,000Nov 21, 2023, 12:19 PM
HRTXHERON THERAPEUTICS, INC. /DE/Forbes William PEVP, Chief Development OfficerNov 16, 2023Buy$0.9450,00046,99554,000Nov 20, 2023, 10:07 AM
HRTXHERON THERAPEUTICS, INC. /DE/Collard Craig AChief Executive OfficerNov 16, 2023Buy$0.92150,000137,970186,496Nov 17, 2023, 12:37 PM
HRTXHERON THERAPEUTICS, INC. /DE/Duarte IraEVP, Chief Financial OfficerNov 16, 2023Buy$0.8985,00075,59985,000Nov 17, 2023, 12:36 PM
HRTXHERON THERAPEUTICS, INC. /DE/Peraza LisaVP, Chief Accounting OfficerJul 25, 2023Option Exercise$1.5114,74322,26253,198Oct 17, 2023, 07:57 PM
HRTXHERON THERAPEUTICS, INC. /DE/Peraza LisaVP, Chief Accounting OfficerOct 13, 2023Option Exercise$0.7286061954,822Oct 17, 2023, 07:57 PM
HRTXHERON THERAPEUTICS, INC. /DE/Collard Craig AChief Executive OfficerAug 22, 2023Option Exercise$1.656921,14236,496Aug 24, 2023, 04:09 PM
HRTXHERON THERAPEUTICS, INC. /DE/Morgan AdamDirectorJul 21, 2023Buy$1.372,486,7443,406,8396,986,744Jul 25, 2023, 04:22 PM
HRTXHERON THERAPEUTICS, INC. /DE/Szekeres David LeslieEVP, Chief Operating OfficerJul 13, 2023Option Exercise$1.312,0122,63633,754Jul 17, 2023, 05:51 PM
HRTXHERON THERAPEUTICS, INC. /DE/Peraza LisaVP, Chief Accounting OfficerJul 13, 2023Option Exercise$1.318601,12725,310Jul 17, 2023, 05:51 PM
HRTXHERON THERAPEUTICS, INC. /DE/Collard Craig AChief Executive OfficerMay 22, 2023Option Exercise$1.456911,00237,188May 24, 2023, 05:04 PM
HRTXHERON THERAPEUTICS, INC. /DE/Szekeres David LeslieEVP, Chief Operating OfficerApr 13, 2023Option Exercise$2.882,0125,79529,952Apr 17, 2023, 05:28 PM
HRTXHERON THERAPEUTICS, INC. /DE/POYHONEN JOHNPresident & CCOApr 13, 2023Option Exercise$2.882,0125,79546,648Apr 17, 2023, 05:27 PM
HRTXHERON THERAPEUTICS, INC. /DE/Peraza LisaVP, Chief Accounting OfficerApr 13, 2023Option Exercise$2.888602,47723,685Apr 17, 2023, 05:27 PM
HRTXHERON THERAPEUTICS, INC. /DE/MANHARD KIMBERLYEVP, Drug DevelopmentApr 13, 2023Option Exercise$2.881,4174,08128,330Apr 17, 2023, 05:26 PM
HRTXHERON THERAPEUTICS, INC. /DE/Szekeres David LeslieEVP, Chief Operating OfficerJan 13, 2023Option Exercise$3.172,0126,37826,150Jan 17, 2023, 05:37 PM
HRTXHERON THERAPEUTICS, INC. /DE/Szekeres David LeslieEVP, Chief Operating OfficerOct 31, 2022Option Exercise$3.271,6545,41322,348Jan 17, 2023, 05:37 PM
HRTXHERON THERAPEUTICS, INC. /DE/Quart Barry DChief Executive OfficerOct 31, 2022Option Exercise$3.271,6555,416163,441Jan 17, 2023, 05:36 PM
HRTXHERON THERAPEUTICS, INC. /DE/Quart Barry DChief Executive OfficerJan 13, 2023Option Exercise$3.175,21916,544177,989Jan 17, 2023, 05:36 PM
HRTXHERON THERAPEUTICS, INC. /DE/POYHONEN JOHNPresident & CCOJan 13, 2023Option Exercise$3.172,0126,37842,846Jan 17, 2023, 05:36 PM
HRTXHERON THERAPEUTICS, INC. /DE/Peraza LisaVP, Chief Accounting OfficerJan 13, 2023Option Exercise$3.171,0133,21122,061Jan 17, 2023, 05:35 PM
HRTXHERON THERAPEUTICS, INC. /DE/MANHARD KIMBERLYEVP, Drug DevelopmentOct 31, 2022Option Exercise$3.271,6555,41620,131Jan 17, 2023, 05:34 PM
HRTXHERON THERAPEUTICS, INC. /DE/MANHARD KIMBERLYEVP, Drug DevelopmentJan 13, 2023Option Exercise$3.172,0126,37823,933Jan 17, 2023, 05:34 PM
HRTXHERON THERAPEUTICS, INC. /DE/Szekeres David LeslieEVP, Chief Operating OfficerOct 13, 2022Option Exercise$3.762,0127,56520,694Oct 17, 2022, 04:38 PM
HRTXHERON THERAPEUTICS, INC. /DE/Quart Barry DChief Executive OfficerOct 13, 2022Option Exercise$3.765,21919,623161,786Oct 17, 2022, 04:38 PM
HRTXHERON THERAPEUTICS, INC. /DE/POYHONEN JOHNPresident & CCOOct 13, 2022Option Exercise$3.762,0127,56539,044Oct 17, 2022, 04:37 PM
HRTXHERON THERAPEUTICS, INC. /DE/Peraza LisaVP, Chief Accounting OfficerOct 13, 2022Option Exercise$3.768613,23720,589Oct 17, 2022, 04:36 PM
HRTXHERON THERAPEUTICS, INC. /DE/MANHARD KIMBERLYEVP, Drug DevelopmentOct 13, 2022Option Exercise$3.762,0127,56518,476Oct 17, 2022, 04:36 PM
HRTXHERON THERAPEUTICS, INC. /DE/Szekeres David LeslieEVP, Chief Operating OfficerApr 29, 2022Option Exercise$3.841,5055,78213,090Jul 15, 2022, 04:58 PM
HRTXHERON THERAPEUTICS, INC. /DE/Szekeres David LeslieEVP, Chief Operating OfficerJul 13, 2022Option Exercise$3.012,0126,05616,892Jul 15, 2022, 04:58 PM
HRTXHERON THERAPEUTICS, INC. /DE/Quart Barry DChief Executive OfficerApr 29, 2022Option Exercise$3.841,5045,778132,688Jul 15, 2022, 04:57 PM
HRTXHERON THERAPEUTICS, INC. /DE/Quart Barry DChief Executive OfficerJul 13, 2022Option Exercise$3.015,21915,709147,237Jul 15, 2022, 04:57 PM
HRTXHERON THERAPEUTICS, INC. /DE/POYHONEN JOHNPresident & CCOJul 13, 2022Option Exercise$3.012,0126,05635,242Jul 15, 2022, 04:56 PM
HRTXHERON THERAPEUTICS, INC. /DE/Peraza LisaVP, Chief Accounting OfficerJul 13, 2022Option Exercise$3.018602,58918,965Jul 15, 2022, 04:55 PM
HRTXHERON THERAPEUTICS, INC. /DE/MANHARD KIMBERLYEVP, Drug DevelopmentJul 13, 2022Option Exercise$3.012,0126,05614,674Jul 15, 2022, 04:55 PM
HRTXHERON THERAPEUTICS, INC. /DE/MANHARD KIMBERLYEVP, Drug DevelopmentApr 29, 2022Option Exercise$3.841,5045,77812,376May 04, 2022, 07:01 PM
HRTXHERON THERAPEUTICS, INC. /DE/MANHARD KIMBERLYEVP, Drug DevelopmentMay 03, 2022Sale$4.761,5047,15410,872May 04, 2022, 07:01 PM
HRTXHERON THERAPEUTICS, INC. /DE/Szekeres David LeslieEVP, Chief Operating OfficerApr 13, 2022Option Exercise$6.072,01212,21311,585Apr 15, 2022, 05:06 PM
HRTXHERON THERAPEUTICS, INC. /DE/Quart Barry DChief Executive OfficerApr 13, 2022Option Exercise$6.075,21931,679131,184Apr 15, 2022, 05:05 PM
HRTXHERON THERAPEUTICS, INC. /DE/POYHONEN JOHNPresident & CCOApr 13, 2022Option Exercise$6.072,01212,21331,440Apr 15, 2022, 05:04 PM
HRTXHERON THERAPEUTICS, INC. /DE/Peraza LisaVP, Chief Accounting OfficerApr 13, 2022Option Exercise$6.078605,22017,340Apr 15, 2022, 05:03 PM
HRTXHERON THERAPEUTICS, INC. /DE/MANHARD KIMBERLYEVP, Drug DevelopmentApr 13, 2022Option Exercise$6.072,01212,21310,872Apr 15, 2022, 05:03 PM
HRTXHERON THERAPEUTICS, INC. /DE/Szekeres David LeslieEVP, Chief Operating OfficerJan 13, 2022Option Exercise$8.302,01216,7007,783Jan 14, 2022, 05:09 PM
HRTXHERON THERAPEUTICS, INC. /DE/Quart Barry DChief Executive OfficerJan 13, 2022Option Exercise$8.305,21943,318116,635Jan 14, 2022, 05:08 PM
HRTXHERON THERAPEUTICS, INC. /DE/POYHONEN JOHNPresident & CCOJan 13, 2022Option Exercise$8.302,01216,70027,638Jan 14, 2022, 05:07 PM
HRTXHERON THERAPEUTICS, INC. /DE/Peraza LisaVP, Chief Accounting OfficerJan 13, 2022Option Exercise$8.309668,01815,716Jan 14, 2022, 05:06 PM
HRTXHERON THERAPEUTICS, INC. /DE/MANHARD KIMBERLYEVP, Drug DevelopmentJan 13, 2022Option Exercise$8.302,01216,7007,070Jan 14, 2022, 05:05 PM
HRTXHERON THERAPEUTICS, INC. /DE/POYHONEN JOHNPresident & CCOOct 29, 2021Option Exercise$9.368177,64623,836Dec 23, 2021, 06:59 PM
HRTXHERON THERAPEUTICS, INC. /DE/Christian WaageDirectorDec 21, 2021Sale$9.733002,9203,200Dec 23, 2021, 06:58 PM
HRTXHERON THERAPEUTICS, INC. /DE/Johnson Craig ADirectorDec 21, 2021Sale$9.732502,4322,840Dec 23, 2021, 06:57 PM
HRTXHERON THERAPEUTICS, INC. /DE/Szekeres David LeslieEVP, Chief Operating OfficerOct 13, 2021Option Exercise$10.554334,5683,981Oct 15, 2021, 04:26 PM
HRTXHERON THERAPEUTICS, INC. /DE/Quart Barry DChief Executive OfficerOct 13, 2021Option Exercise$10.5596310,160102,086Oct 15, 2021, 04:25 PM
HRTXHERON THERAPEUTICS, INC. /DE/POYHONEN JOHNPresident & CCOOct 13, 2021Option Exercise$10.554334,56823,019Oct 15, 2021, 04:24 PM
HRTXHERON THERAPEUTICS, INC. /DE/Peraza LisaVP, Chief Accounting OfficerOct 13, 2021Option Exercise$10.551912,01514,197Oct 15, 2021, 04:23 PM
HRTXHERON THERAPEUTICS, INC. /DE/MANHARD KIMBERLYEVP, Drug DevelopmentOct 13, 2021Option Exercise$10.554334,5683,268Oct 15, 2021, 04:22 PM
HRTXHERON THERAPEUTICS, INC. /DE/Christian WaageDirectorSep 21, 2021Sale$12.313003,6923,500Sep 23, 2021, 04:30 PM
HRTXHERON THERAPEUTICS, INC. /DE/Johnson Craig ADirectorSep 21, 2021Sale$12.302503,0743,090Sep 23, 2021, 04:29 PM
HRTXHERON THERAPEUTICS, INC. /DE/Szekeres David LeslieEVP, Chief Operating OfficerApr 30, 2021Option Exercise$13.901,53021,2632,347Jul 15, 2021, 04:52 PM
HRTXHERON THERAPEUTICS, INC. /DE/Szekeres David LeslieEVP, Chief Operating OfficerJul 13, 2021Option Exercise$13.484335,8373,164Jul 15, 2021, 04:52 PM
HRTXHERON THERAPEUTICS, INC. /DE/Quart Barry DChief Executive OfficerJul 13, 2021Option Exercise$13.4896312,98199,403Jul 15, 2021, 04:50 PM
HRTXHERON THERAPEUTICS, INC. /DE/Quart Barry DChief Executive OfficerApr 30, 2021Option Exercise$13.901,52921,24996,721Jul 15, 2021, 04:50 PM
HRTXHERON THERAPEUTICS, INC. /DE/POYHONEN JOHNPresident & CCOApr 30, 2021Option Exercise$13.9097113,49421,385Jul 15, 2021, 04:49 PM
HRTXHERON THERAPEUTICS, INC. /DE/POYHONEN JOHNPresident & CCOJul 13, 2021Option Exercise$13.484335,83722,202Jul 15, 2021, 04:49 PM
HRTXHERON THERAPEUTICS, INC. /DE/Peraza LisaVP, Chief Accounting OfficerApr 30, 2021Option Exercise$13.901,53021,26313,475Jul 15, 2021, 04:48 PM
HRTXHERON THERAPEUTICS, INC. /DE/Peraza LisaVP, Chief Accounting OfficerJul 13, 2021Option Exercise$13.481912,57513,836Jul 15, 2021, 04:48 PM
HRTXHERON THERAPEUTICS, INC. /DE/MANHARD KIMBERLYEVP, Drug DevelopmentJul 13, 2021Option Exercise$13.484335,8372,451Jul 15, 2021, 04:47 PM
HRTXHERON THERAPEUTICS, INC. /DE/Johnson Craig ADirectorJun 21, 2021Sale$15.202503,8013,340Jun 22, 2021, 05:05 PM
HRTXHERON THERAPEUTICS, INC. /DE/Christian WaageDirectorApr 15, 2021Sale$17.513005,2544,100Apr 16, 2021, 08:59 PM
HRTXHERON THERAPEUTICS, INC. /DE/Szekeres David LeslieEVP, Chief Operating OfficerApr 13, 2021Option Exercise$16.664337,214817Apr 15, 2021, 04:55 PM
HRTXHERON THERAPEUTICS, INC. /DE/Quart Barry DChief Executive OfficerApr 13, 2021Option Exercise$16.6696316,04495,192Apr 15, 2021, 04:54 PM
HRTXHERON THERAPEUTICS, INC. /DE/POYHONEN JOHNPresident & CCOApr 13, 2021Option Exercise$16.664337,21420,414Apr 15, 2021, 04:53 PM
HRTXHERON THERAPEUTICS, INC. /DE/Peraza LisaVP, Chief Accounting OfficerApr 13, 2021Option Exercise$16.661913,18211,945Apr 15, 2021, 04:52 PM
HRTXHERON THERAPEUTICS, INC. /DE/MANHARD KIMBERLYEVP, Drug DevelopmentApr 13, 2021Option Exercise$16.664337,2141,634Apr 15, 2021, 04:51 PM
HRTXHERON THERAPEUTICS, INC. /DE/Johnson Craig ADirectorApr 06, 2021Sale$17.222504,3053,590Apr 07, 2021, 05:04 PM
HRTXHERON THERAPEUTICS, INC. /DE/Szekeres David LeslieEVP, Chief Operating OfficerJan 13, 2021Option Exercise$18.164237,682827Jan 15, 2021, 04:30 PM
HRTXHERON THERAPEUTICS, INC. /DE/Szekeres David LeslieEVP, Chief Operating OfficerJan 14, 2021Sale$18.0982714,9600Jan 15, 2021, 04:30 PM
HRTXHERON THERAPEUTICS, INC. /DE/Quart Barry DChief Executive OfficerJan 13, 2021Option Exercise$18.1696317,48891,909Jan 15, 2021, 04:29 PM
HRTXHERON THERAPEUTICS, INC. /DE/POYHONEN JOHNPresident & CCOJan 13, 2021Option Exercise$18.164337,86319,597Jan 15, 2021, 04:27 PM
HRTXHERON THERAPEUTICS, INC. /DE/Peraza LisaVP, Chief Accounting OfficerJan 13, 2021Option Exercise$18.162274,12211,584Jan 15, 2021, 04:26 PM
HRTXHERON THERAPEUTICS, INC. /DE/MANHARD KIMBERLYEVP, Drug DevelopmentJan 13, 2021Option Exercise$18.164337,863817Jan 15, 2021, 04:25 PM
HRTXHERON THERAPEUTICS, INC. /DE/Szekeres David LeslieEVP, Chief Operating OfficerJan 08, 2021Sale$19.663,57170,2190Jan 08, 2021, 06:07 PM
HRTXHERON THERAPEUTICS, INC. /DE/POYHONEN JOHNPresident & CCOOct 30, 2020Option Exercise$11.656377,42318,780Dec 23, 2020, 04:24 PM
HRTXHERON THERAPEUTICS, INC. /DE/MANHARD KIMBERLYEVP, Drug DevelopmentDec 22, 2020Option Exercise$16.5020,000330,00010,000Dec 23, 2020, 04:23 PM
HRTXHERON THERAPEUTICS, INC. /DE/Quart Barry DChief Executive OfficerApr 30, 2020Option Exercise$12.121,15814,03689,226Oct 15, 2020, 04:23 PM
HRTXHERON THERAPEUTICS, INC. /DE/MANHARD KIMBERLYExecutive VP, Drug DevelopmentApr 30, 2020Option Exercise$12.121,15814,0361,158May 01, 2020, 06:48 PM
HRTXHERON THERAPEUTICS, INC. /DE/MANHARD KIMBERLYExecutive VP, Drug DevelopmentMay 01, 2020Sale$13.971,15816,1760May 01, 2020, 06:48 PM
HRTXHERON THERAPEUTICS, INC. /DE/MANHARD KIMBERLYExecutive VP, Drug DevelopmentNov 29, 2019Sale$19.5048,000936,00024,000Dec 03, 2019, 06:30 PM
HRTXHERON THERAPEUTICS, INC. /DE/TANG KEVIN CDirectorOct 04, 2019Buy$17.50285,7144,999,9955,799,810Oct 07, 2019, 05:18 PM
HRTXHERON THERAPEUTICS, INC. /DE/Quart Barry DChief Executive OfficerApr 30, 2019Option Exercise$18.4380614,85390,081Oct 04, 2019, 07:58 PM
HRTXHERON THERAPEUTICS, INC. /DE/Quart Barry DChief Executive OfficerOct 03, 2019Buy$17.504,57179,99394,652Oct 04, 2019, 07:58 PM
HRTXHERON THERAPEUTICS, INC. /DE/POYHONEN JOHNEVP, Chief Commercial OfficerOct 03, 2019Buy$17.505,14390,00318,143Oct 04, 2019, 07:56 PM
HRTXHERON THERAPEUTICS, INC. /DE/POYHONEN JOHNDirectorMay 22, 2019Buy$17.553,00052,65013,000May 23, 2019, 08:39 AM
HRTXHERON THERAPEUTICS, INC. /DE/Christian WaageDirectorMay 15, 2019Buy$18.041,40025,2621,400May 16, 2019, 08:44 AM
HRTXHERON THERAPEUTICS, INC. /DE/MANHARD KIMBERLYExecutive VP, Drug DevelopmentApr 30, 2019Option Exercise$18.431,10920,4371,109May 02, 2019, 08:40 PM
HRTXHERON THERAPEUTICS, INC. /DE/MANHARD KIMBERLYExecutive VP, Drug DevelopmentMay 01, 2019Sale$18.861,10920,9180May 02, 2019, 08:40 PM
HRTXHERON THERAPEUTICS, INC. /DE/MANHARD KIMBERLYExecutive VP, Drug DevelopmentOct 31, 2018Option Exercise$23.6049411,656494Nov 02, 2018, 09:17 PM
HRTXHERON THERAPEUTICS, INC. /DE/MANHARD KIMBERLYExecutive VP, Drug DevelopmentNov 02, 2018Sale$30.6249415,1250Nov 02, 2018, 09:17 PM
HRTXHERON THERAPEUTICS, INC. /DE/MANHARD KIMBERLYExecutive VP, Drug DevelopmentOct 01, 2018Option Exercise$22.5412,000270,4336,000Oct 02, 2018, 09:12 PM
HRTXHERON THERAPEUTICS, INC. /DE/Quart Barry DChief Executive OfficerSep 14, 2018Option Exercise$7.2019,675141,66089,275Sep 14, 2018, 11:41 AM